The results of this study showed that human glioblastoma U87MG cells expressed integrin-αvβ3, were up-regulated by a pre-treatment of low-dose PTX, and underwent programmed cell death through the activation of caspase-3, -8, -9, -10 and -12. The gene discussed is CASP3; the disease is glioblastoma.